# Multicohort Trial of Trabectedin and Low-dose Radiation Therapy in Advanced/Metastatic Sarcomas

> **NCT05131386** · PHASE2 · UNKNOWN · sponsor: **Grupo Espanol de Investigacion en Sarcomas** · enrollment: 85 (estimated)

## Conditions studied

- Soft Tissue Sarcoma
- Bone Tumors
- Small Round-cell Sarcomas

## Interventions

- **DRUG:** Trabectedin

## Key facts

- **NCT ID:** NCT05131386
- **Lead sponsor:** Grupo Espanol de Investigacion en Sarcomas
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-05-28
- **Primary completion:** 2024-07-28
- **Final completion:** 2024-07-28
- **Target enrollment:** 85 (ESTIMATED)
- **Last updated:** 2023-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05131386

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05131386, "Multicohort Trial of Trabectedin and Low-dose Radiation Therapy in Advanced/Metastatic Sarcomas". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT05131386. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*